These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 12488492
21. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies. Kitaichi N, Matsuda A, Kotake S, Namba K, Tagawa Y, Sasamoto Y, Ogasawara K, Iwabuchi K, Onoé K, Matsuda H, Nishihira J. Curr Eye Res; 2000 Feb; 20(2):109-14. PubMed ID: 10617911 [Abstract] [Full Text] [Related]
22. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody. Namba K, Ogasawara K, Kitaichi N, Morohashi T, Sasamoto Y, Kotake S, Matsuda H, Iwabuchi K, Iwabuchi C, Ohno S, Onoé K. J Immunol; 2000 Sep 15; 165(6):2962-9. PubMed ID: 10975803 [Abstract] [Full Text] [Related]
24. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. Exp Eye Res; 2008 Oct 15; 87(4):319-26. PubMed ID: 18634784 [Abstract] [Full Text] [Related]
25. Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis. Calder VL, Zhao ZS, Wang Y, Barton K, Lightman SL. Immunology; 1993 Jun 15; 79(2):255-62. PubMed ID: 8102121 [Abstract] [Full Text] [Related]
26. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Kurose S, Ikeda E, Tokiwa M, Hikita N, Mochizuki M. Exp Eye Res; 2000 Jan 15; 70(1):7-15. PubMed ID: 10644416 [Abstract] [Full Text] [Related]
33. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H. Int Immunol; 2008 Feb 15; 20(2):209-14. PubMed ID: 18156624 [Abstract] [Full Text] [Related]
34. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice. Nomizo A, Postol E, de Alencar R, Cardillo F, Mengel J. Immunology; 2005 Oct 15; 116(2):233-44. PubMed ID: 16162272 [Abstract] [Full Text] [Related]
35. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice. Chen J, Vistica B, Wiggert B, Chan CC, Gery I. Ocul Immunol Inflamm; 2005 Feb 15; 13(1):13-7. PubMed ID: 15804764 [Abstract] [Full Text] [Related]